DefiniGEN is a startup based in the United Kingdom, 2 tracked investors.
Based in the United Kingdom, DefiniGEN is a startup. Brouky records 2 investors associated with the company.
DefiniGEN uses stem cell technology and artificial intelligence to produce human cell lines for research and drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.